Market Tracker

02/12 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

10.45
Delayed Data
As of Feb 12
 -0.03 / -0.29%
Today’s Change
9.91
Today|||52-Week Range
25.56
-29.58%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close10.48
Today’s open10.62
Day’s range9.91 - 10.62
Volume935,115
Average volume (3 months)757,598
Market cap$721.0M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+51.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
RLYPRelypsa Inc+0.27+1.57%
PACBPacific Biosciences ...-0.13-1.40%
AIMTAimmune Therapeutics...+0.09+0.56%
FPRXFive Prime Therapeut...+0.31+1.07%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts